Clinic Aspects
  • Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019 Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019 #8636_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:Zhang Ting

    Abstract: Severe acute respiratory syndrome (SARS) and coronavirus disease 2019 (COVID-19) shared similar pathogenetic, clinical and pathological features. Fever and cough were the most common symptoms of both diseases, while myalgia and diarrhea were less common in patients with COVID-19. Acute respiratory distress syndrome (ARDS) was the most severe pulmonary complication that caused high mortality rate. Histologically, diffuse alveolar damage (DAD) was the most characteristic finding in non-survivors with either SARS or COVID-19. Cases of patients died less than 10~14 days of disease duration demonstrated acute-phase DAD, while cases beyond 10~14 days of disease duration exhibited organizing-phase DAD in SARS. Meanwhile, organization and fibrosis were usually accompanied by exudation. Coronavirus was mostly detected in pneumocytes, while less in macrophages and bronchiolar epithelial cells. Hemorrhagic necrosis and lymphocytes depletion were found in lymph nodes and spleen in both SARS and COVID-19, indicating a pathological basis of lymphocytopenia. Thrombosis was commonly observed in small vessels and microvascular in lungs accompanying DAD. Microthrombosis was also found in extrapulmonary organs in COVID-19, that was less reported in SARS. Damages in multiple extrapulmonary organs were observed, but coronavirus was not detected in some of those organs, might indicating an alternative mechanism beyond viral infection, such as hypoxemia, ischemia and cytokine storm induced immunological injury. Diffuse alveolar damage due to viral infection and immunological injury, as well as multi-organ dysfunction and extensive microthrombus formation, brought huge challenge to the management of patients with severe SARS or COVID-19.

    Journal:Chinese Journal of Tuberculosis and Respiratory Diseases

    Publishing Time:2020,43(00):E040-E040

    DOI:10.3760/cma.j.cn112147-20200311-00312

  • The comparison of nucleic acid detections between throat swab and stool specimens in SARS-CoV-2 infection patients The comparison of nucleic acid detections between throat swab and stool specimens in SARS-CoV-2 infection patients #8632_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:Li Bo

    Abstract: Objective The nucleic acid detections is 'golden standard’ for the novel coronavirus infection confirmation. In the present study,we evaluated the positive rate of nucleic acid detections in throat swab and stool specimens of patients, our study will provide a reference to the clinical laboratory diagnosis. Methods Forty-one confirmed patients were enrolled in our study, their throat swab and stool specimens were collected for detections. All the samples were determined by a fluorescence quantitative PCR method. The positive rate and concordance were evaluated in these two types of samples. Results Among those 41 patients, 9 of them had positive results in throat swab samples,accounted for 30%. Five patients had positive results in stool samples, accounted for 12.2%. Only two patients had concordant positive results. Kappa tests showed that theconcordance was poor, kappa indexwas 0.153. Conclusion The nucleic acid detection in stool specimen is a complemental method for respiratory tract samples. It can contribute to the elevation of positive rates in patients. In addition, there is potential infectiousness in stool of patients, it may be a new transmission way for the infection.

    Journal:Chinese Journal of Experimental and Clinical Virology

    Publishing Time:2020,34(00):E008-E008

    DOI:10.3760/cma.j.cn112866-20200303-00041

  • The significance of revising diagnosis and treatment plan for reducing missed diagnosis of novel coronavirus pneumonia The significance of revising diagnosis and treatment plan for reducing missed diagnosis of novel coronavirus pneumonia #8631_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:Wu Weigang

    Abstract: Analysis of a case of an elderly patient visiting relatives from Wuhan to Shenzhen on January 19,2020 who was been diagnosed of COVID-19 and isolated after two visits on January 21 and January 29. According to the 'diagnostic and treatment options of the novel coronavirus pneumonia (trial version)' issued by National Health Commission of the People’s Republic of China on January 15, the patient can only be isolated at home because he did not met the diagnostic standard of 'suspected case' on January 21. But on January 21, the patient met the criteria and must be isolated in hospital according to the new 'diagnostic and treatment options of the novel coronavirus pneumonia (the 4th version)' issued on January 27 which .Therefore,it is suggested that during the outbreak of new infectious diseases, the diagnostic and treatment options should be revised quickly and reasonably for reducing the missed diagnosis and control the spread of infectious diseases.

    Journal:Chinese Journal of Experimental and Clinical Virology

    Publishing Time:2020,34(00):E007-E007

    DOI:10.3760/cma.j.issn.1003-9279.2020.0007

  • Effectiveness evaluation ofapplyingan intelligent voice callsystem on the popular science knowledge of Corona Virus Disease 2019 for the patients with chronic diseases in the community Effectiveness evaluation ofapplyingan intelligent voice callsystem on the popular science knowledge of Corona Virus Disease 2019 for the patients with chronic diseases in the community #8630_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:Wei Xuejuan

    Abstract: Objective To improve the contracted patients’cognitive level and self-protection ability ofCorona Virus Disease 2019 (COVID-19)through the popularizationeducation with the application of an intelligent voice outbound system. Methods 12 popular science education modules ware designed according to the knowledge and protective measures ofCOVID-19, and3-6 core points were extracted from each module. From Wuhan city blocked 2020.1.23 to 2020.1.29, the intelligent voice outbound system was applied toperform batch voice call calls and send text messages to all contracted patients with chronic diseases in different period of time for popular science education.Using equidistant sampling method, 400 cases were successfully selectedfrom the patients of successful voice outbound calls.The intelligent voice outbound system was used to investigatepatients' mastery, the main sources ofCOVID-19knowledge, and satisfaction with popular science education conducted in this study. The outbound results of the above indicators were queried from the database of the intelligent voice outbound system. Results A total of 98,487 voice outbound calls were effectively connected,the average call duration per person was 2.24 minutes, and the total call durationwas equivalent to 488.5 workdays. 141,201 messages were sent, with a read rate of 97.8% (141 201/144 405) . The patients’scoreto answer the popular science knowledge questionnaire was 86.8±16.7.94.8% (235/248) of patients’knowledge of COVID-19mainly came from voice call.In addition, the patient's overall satisfaction with the application of the intelligent voice call system for popular science education was90.8%(225/248). Conclusion The patients’cognitive levelofCOVID-19knowledge and its prevention and control measureseffectively improved with the application of an intelligent voice outbound system. Moreover, this mode was highly acceptable to patients, whichshould be referenced by other urban communities in China.

    Journal:Chinese Journal of General Practitioners

    Publishing Time:2020,19(00):E008-E008

    DOI:10.3760/cma.j.cn114798-20200220-00143

  • Medical coping modes and influencing factors of 128 patients with COVID-2019 Medical coping modes and influencing factors of 128 patients with COVID-2019 #8629_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:Shen Yuehao

    Abstract: Objective To explore the relationships between medical coping modes of patients with COVID-2019 and general information and social supports. Methods From January to February 2020, a total of 128 patients in a designated hospital in Wuhan with novel coronavirus pneumonia were investigated using the General Information Questionnaire and the Chinese version of the Medical Coping Modes Questionnaire(MCMQ) by convenient sampling. Pearson univariate analysis and multiple linear regression were used to analyze the relationship between the basic situation of patients with novel coronavirus pneumonia and coping modes. Results The scores of the face dimension and yield dimension of patients with COVID-2019 were lower than the norm model, while the avoidance dimension was higher than the norm model, and the differences were statistically significant ( P <0.05). Support utilization and complexity were influencing factors of the face dimension ( P <0.05). Support utilization and age were influencing factors of the yielding dimension ( P <0.01). Subjective support, the complexity dimension of disease uncertainty and the number of confirmed patients in the family were influencing factors of the avoidance dimension ( P <0.01). Conclusions Patients with COVID-2019 have poor medical coping modes, and they are prone to face the disease with a negative attitude. Patients are unwilling to face the disease and the tendency to yield to the disease is greater. And the older the patients, the less likely they are to succumb to the disease. The more patients diagnosed in the family, the less likely they are to avoid the disease. Patients with higher social supports and utilization have a more reasonable medical coping mode. This reminds medical staff to pay more attention to the psychological problems of patients in coping with COVID-2019 and improve their coping modes and methods.

    Journal:Chinese Journal of Modern Nursing

    Publishing Time:2020,26(00):E015-E015

    DOI:10.3760/cma.j.cn115682-20200221-00933

  • Severe novel coronavirus pneumonia in type 2 diabetes: A case report Severe novel coronavirus pneumonia in type 2 diabetes: A case report #8628_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:Peng Shaolin

    Abstract:Chest pain, body temperature up to 39.8 ℃, with myalgia, chills, poor appetite and fatigue discomfort. There was a 5-year history of "type 2 diabetes" and poor blood glucose control. Have contact history with those who have fever and cough. Physical examination of symptoms and signs: clear mind, poor spirit, small tonsil, no congestion and edema in the pharynx, thick breath sounds in both lungs, no obvious dry and wet rales, no Murs. The abdomen is soft, without tenderness and rebound pain, without liver and spleen, without edema in both legs. On the 7th day of admission, the patient had no fever, cough and expectoration were more serious than before, the sputum was increased, the sputum was yellow and thick, and there was shortness of breath. The obvious moist rale of lung began to appear and lasted for 1 week, and cyanosis appeared on the 8th day, the respiratory rate was more than 30 times / min. The diagnosis methods were improved after admission. Chest CT examination is novel coronavirus pneumonia. The novel coronavirus was positive for nucleic acid detection. The patients were treated in separate isolation ward. To give antiviral, anti infection, hypoglycemic, improve immunity, clinical outcome of glucocorticoid treatment. The clinical outcome of novel coronavirus pneumonia gradually progressed to severe after the diagnosis of the disease. After comprehensive treatment, the patient gradually stabilized and discharged. After discharge, the laboratory indexes improved significantly, and the absorption of lesions decreased significantly on imaging. Suitable for reading: respiratory department; Endocrinology Department

    Journal:Chinese Medical Case Repository

    Publishing Time:2020,02(01):E020-E020

    DOI:10.3760/cma.j.cmcr.2020.e00016

  • Death of a neonate born to a critically ill mother with COVID-19: a case report Death of a neonate born to a critically ill mother with COVID-19: a case report #8626_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:He Shuming

    Abstract: We report a critically ill pregnant woman in the third trimester with severe pneumonia due to COVID-19 who presented to Xiaolan People's Hospital of Zhongshan in February 2020. The 32-year-old patient was admitted at 35 +2 gestational weeks with a 4-day history of a sore throat and a fever for three hours. The patient had been to Xiaogan City, Hubei Province, and the symptoms occurred during a period of self-isolation after back home. The condition of the patient deteriorated rapidly, with left-sided chest and back pain, shortness of breath, dizziness, progressing to respiratory failure and septic shock 7 hours after her admission. In view of her critical condition and a history of two previous cesarean sections, an emergency cesarean section was performed. Blood gas analysis of the mother before the operation suggested respiratory failure, respiratory acidosis, and metabolic acidosis. During the operation, a baby boy was born. The Apgar score of the boy, birth weight of 2 700 g, was one at 1, 5 and 10 minutes despite the resuscitation efforts. The neonate died after withdrawing treatment. The patient was treated with tracheal intubation ventilator and other supportive treatments after the operation. The result of the new coronavirus nucleic acid test, taken on admission, but which was reported after delivery, was positive. The patient was transferred to the designated hospital for further treatment and was recovering with the withdrawal of extracorporeal membrane oxygenation and ventilation support at 26 and 36 days after surgery, respectively.

    Journal:Chinese Journal of Perinatal Medicine

    Publishing Time:2020,23(04):217-220

    DOI:10.3760/cma.j.cn113903-20200228-00171

  • Optional antiviral agents for the 2019 novel coronavirus and the liver injury Optional antiviral agents for the 2019 novel coronavirus and the liver injury #8625_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:Yang Ping

    Abstract: The most important treatment of anti 2019 novel coronavirus is antiviral and supportive treatment. Currently, the anti novel coronavirus drugs in clinical trials include broad-spectrum antiviral drugs (Alpha interferon and Ribavirin), hemagglutinin inhibitors (Arbidol), human immunodeficiency virus protease inhibitors (Lopinavir/Ritonavir and Darunavir/Cobicistat), nucleoside analogues (Favipiravir and Remdesivir) and antimalarial drug (chloroquine), however, some patients suffered from liver damage during the actual usage. This article reviews the research on liver damage associated with anti novel coronavirus drugs, aiming at promoting the rational, safe and effective use of anti novel coronavirus drugs.

    Journal:Chinese Journal of Clinical Infectious Diseases

    Publishing Time:2020,13(00):E011-E011

    DOI:10.3760/cma.j.cn115673-20200214-00034

  • Clinical application effect of modified nasopharyngeal swab sampling for 2019novel coronavirus nucleic acid detection Clinical application effect of modified nasopharyngeal swab sampling for 2019novel coronavirus nucleic acid detection #8623_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:Ma Siyuan

    Abstract: Objective To study the clinical application effect of modified nasopharyngeal swab sampling for 2019 novel coronavirus nucleic acid detection. Methods This study covered the period from January 14 to March 1, 2020. From February 24 on, the supine position method and the protective face screen were used to collect nasopharyngeal swabs, before which, the nasopharyngeal swabs were collected by sitting position method. All the patients were diagnosed with suspected/confirmed 2019 novel coronavirus infection, who were admitted from February 19 on, before which, the nasopharyngeal swabs were collected outside the hospital. (1) Thirty-four operators meeting the inclusion criteria of the study were recruited in this retrospective cohort study. They were grouped according to the collection method of nasopharyngeal swabs. Sixteen operators of Wuhan Taikang Tongji Hospital who used the supine position method and the protective face screen were included in supine position method+protective face screen group (15 males and 1 female, aged 34-49 years); 18 operators (12 from the First Affiliated Hospital of Army Medical University (the Third Military Medical University), 1 from Wuhan Jiangxia Mobile Cabin Hospital, 5 from the East District of People's Hospital of Wuhan University) who used the traditional sitting position method were included in sitting position method group (2 males and 16 females, aged 25-49 years). In supine position method+protective face screen group, when collecting sample, the patient lay flat and wore a special protective face screen for nasopharyngeal swab sampling, with neck slightly extending and face turning to the opposite side of the operator about 10°. The self-designed questionnaire was used to investigate the cooperation, the incidence of nausea, coughing, sneezing, and struggling of patients evaluated by the operators, the operation time of single sampling, the fear of operation and the perceived exposure risk of operators of the two groups. (2) Sixty-five patients (22 males and 43 females, aged 25-91 years) admitted to Wuhan Taikang Tongji Hospital who successively received the sitting position method and supine position method+protective face screen for nasopharyngeal swabs sampling and with complete nucleic acid detection results were included. The positive rates of nucleic acid detection by the two sampling methods of nasopharyngeal swabs of the patients were statistically analyzed. (3) Forty-one patients who could express their feelings accurately were selected from the above 65 patients (12 males and 29 females, aged 27-83 years). The comfort of patients in the process of sampling by the two methods was investigated. (4) Thirty-four patients (10 males and 24 females, aged 25-83 years) with two or more consecutive negative results of nucleic acid detection of nasopharyngeal swabs by sitting position method were selected from the above 65 patients. The positive rate of nucleic acid detection of nasopharyngeal swab of patients by supine position method+protective face screen, i.e. negative to positive rate was statistically analyzed. Data were statistically analyzed with Wilcoxon's sign rank test, t test, and chi-square test. Results (1) The cooperation score of patients evaluated by the operators in supine position method+protective face screen group was significantly higher than that in sitting position method group ( Z =-4.928, P <0.01), the incidence of nausea, choking cough, sneezing, and struggling of patients evaluated by the operators, and the fear of operation score and the perceived exposure risk score of operators were significantly lower than those of sitting position method group ( Z =-5.071, -5.046, -4.095, -4.397, -4.174, -5.049, P <0.01), and the operation time of single sampling was significantly longer than that of sitting position method group ( t =23.17, P <0.01). (2) The positive rate of nucleic acid detection of nasopharyngeal swabs by supine position method+protective face screen was 60.00% (39/65), which was obviously higher than 41.54% (27/65) by sitting position method ( χ 2 =4.432, P <0.05). (3) The comfort score of the 41 patients during nasopharyngeal swabs sampling by supine position method+protective face screen was significantly higher than that by sitting position method ( Z =-5.319, P <0.01). (4) Of the 34 patients with two or more consecutive negative results of nucleic acid detection of nasopharyngeal swabs by sitting position method, the rate of negative to positive of nucleic acid detection was 26.47% (9/34) after sampling by supine position method+protective face screen. Conclusions Compared with the traditional sitting position method, detection of 2019 novel coronavirus nucleic acids of nasopharyngeal swabs collected by supine method combined with protective face screen is worth promoting, because of its better comfort of patients, low exposure risk for operators, in addition to reducing in the false negative result to some extent, which may help reduce false recurrence of discharged patients.

    Journal:Chinese Journal of Burns

    Publishing Time:2020,36(00):E009-E009

    DOI:10.3760/cma.j.cn501120-20200312-00153

  • Treatment experience of burn patients combined with inhalation injury during epidemic period of Corona Virus Disease 2019 Treatment experience of burn patients combined with inhalation injury during epidemic period of Corona Virus Disease 2019 #8622_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:Jiang Nanhong

    Abstract: Objective To introduce Treatment experience of burn patients combined with inhalation injury during epidemic period of Corona Virus Disease 2019 (COVID-19). Methods Six burn patients combined with inhalation injury were hospitalized in Department of Burns of Tongren Hospital of Wuhan University& Wuhan Third Hospital from February 1 to March 1 in 2020duringhigh-incidence period of COVID-19, including 4 males and 2 females, aged 21-63 years, hospitalized for 2-4 hours, with total burn areas of 1%-20% TBSA and full-thickness burn areas of 1%-12% TBSA. Among them, 1 case was severe inhalation injury, 2 cases were mild inhalation injury, and 3 cases were moderate inhalation injury. The body temperatures of the patients were normal at admission without fever or cough in the past 2 weeks. At admission, chest CT of one patient showed double lower lobes and left upper lobes had multiple slices and slightly high-density shadow of nodules. Chest CT of two patients showed bilateral lung texture was thickening, and chest CT of other patients was normal. After admission, 6 patients were given routine treatment, the medical staffs paid attention to the protection and screened COVID-19 according to the diagnosis and treatment plan of COVID-19. On post injury day (PID) 1, 3, 6, and 9, vein blood of patients were collected for determination of white blood cell (WBC) count, neutrophil, lymphocyte absolute value. and level of procalcitonin (PCT). Nucleic acid of novel coronavirus was detected by real-time fluorescence reverse transcription polymerase chain reaction on PID 3 and 6. The temperatures of patients were recorded after admission. The results of chest CT within one week after injury and the prognosis of the patients were recorded. Measurement data distributed normally were expressed as /shaoshang/articleFiles/2018/1/1/images/1009-2587-36-0007-F902c.png'/> ± s, and measurement data distributed abnormally were expressed as M (P 25 , P 75 ) . Results (1) On PID1, 3, 6, and 9, WBC counts of patients were respectively (19.8±3.8)×10 9 /L, (17.2±3.4)×10 9 /L,(13.3±3.1)×10 9 /L, and (11.1±1.6)×10 9 /L, neutrophils of patients were respectively0.919±0.019,0.899±0.011, 0.855±0.034, and0.811±0.035, absolute values of lymphocytes of patients were respectively(0.65±0.18)×10 9 /L,(0.65±0.24)×10 9 /L,(0.91±0.34)×10 9 /L, and (1.23±0.42)×10 9 /L,and PCT values of patients were respectively0.49 (0.36, 1.64), 0.39 (0.26, 0.73), 0.28 (0.18, 0.33), and 0.12 (0.11, 0.20) ng/mL.The values of WBC and neutrophils of patients were higher than the normal value, showing a downward trend. The absolute values of lymphocyte of patients returned to the normal value gradually. The PCT values of patients were higher than the normal value. (2) Nucleic acid test results of novel coronavirus of 6 patients were negative on PID 3 and 6. The temperatures of patients were from 36.5 to 38.6 ℃. The typical imaging features of COVID-19 were not found in 6 patients within 1 week after injury by chest CT. After treatment for 14-32 days, 6 patients were cured and discharged. Conclusions During the novel coronavirus, burn patients combined with inhalation injury should be treated under condition of good protection for COVID-19 among doctors and nurses. Meanwhile, virus should be actively screened to reduce the risk of COVID-19 infection among doctors and patients.

    Journal:Chinese Journal of Burns

    Publishing Time:2020,36(00):E007-E007

    DOI:10.3760/cma.j.cn501120-20200308-00135

  • Common Skin Diseases and the response strategies for Medical Staff during the period of COVID-19 Common Skin Diseases and the response strategies for Medical Staff during the period of COVID-19 #8617_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:ZHANG MEI

    Abstract:COVID-19 is needed for medical staff to take preventive measures. They need to wear multiple protective equipment for a long time, frequent exposure to disinfectant materials, and psychological pressure. This paper focuses on the treatment and protective measures of the three most common skin diseases, including pressure injury, allergic dermatitis and tinea pedis, in order to provide reference for the self skin care of the first-line medical staff.

    Journal:Journal of Modern Medicine & Health

    Publishing Time:2020,36(19):37-38

    DOI:

  • Analysis of clinical features of 42 cases of new coronavirus pneumonia Analysis of clinical features of 42 cases of new coronavirus pneumonia #8611_0

    http://rs.yiigle.com/yufabiao/118...

    Info↓

    Author:LIU Sai-duo

    Abstract: [Objective] To investigate the clinical features, laboratory findings, chest CT findings and treatment of 42 patients with 2019-ncov pneumonia after discharge from our hospital, and to analyze their relationship with prognosis. [Methods] from January 2020 to February 2020, the clinical data of 42 patients with 2019-ncov pneumonia admitted to the sixth people's Hospital of Wenzhou City were analyzed retrospectively. [Results] the clinical symptoms of 42 cases included fever (35 cases) , cough (26 cases) , fatigue (14 cases) , sore throat (4 cases) , Muscle Ache (5 cases) , headache (2 cases) , nausea (4 cases) , diarrhea (6 cases) , aspiration (9 cases) and abdominal pain (1 case) . The absolute number of blood lymphocyte decreased in different degree, more than half of the patients Lactate dehydrogenase obviously, the PROCALCITONIN (PCT) had no obvious change, the imaging manifestations were cloud-like and ground-glass-like high density shadows scattered outside the lungs, small flaky consolidation and bronchus inflating sign were seen locally. A few images showed diffuse high density, most of the lesions showed consolidation or striate change, and local fibrosis was formed in the lower lobes of both lungs. [Conclusion] Fever and cough are the first symptoms of 2019-ncov pneumonia, and a few cases are associated with shortness of breath and diarrhea, accompanied by different degrees of systemic symptoms, most of the patients improved. The disease is highly infectious and its condition changes rapidly. Therefore, early detection, early diagnosis and comprehensive treatment of the whole body as soon as possible are the keys to treatment.

    Journal:Shanghai Journal of Preventive Medicine

    Publishing Time:2020,32(04):E090-E090

    DOI:10.19428/j.cnki.sjpm.2020.20092

  • Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial (Gautret et al Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial (Gautret et al #8558_0

    https://www.medrxiv.org/content/1...

    Info↓

    Author:Andrew A. Lover

    Abstract:

    Journal:medRxiv

    Publishing Time:preprint

    DOI:10.1101/2020.03.22.20040949.

  • Non-Pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality Non-Pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality #8555_0

    https://papers.ssrn.com/sol3/pape...

    Info↓

    Author:Gandhi

    Abstract:

    Journal:SSRN

    Publishing Time:eprint

    DOI:10.2139/ssrn.3560688

  • Modelling SARS-CoV-2 Dynamics: Implications for Therapy Modelling SARS-CoV-2 Dynamics: Implications for Therapy #8552_0

    https://www.medrxiv.org/content/1...

    Info↓

    Author:Kwang Su Kim

    Abstract:

    Journal:medRxiv

    Publishing Time:preprint

    DOI:10.1101/2020.03.23.20040493